pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$SDGRSchrodinger, Inc.

$SDGR18.63-0.11%
New York, NY, USupdated 15h ago
SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0

Pipeline(2)

pipeline depth2 products
Phase 1: 2
2Phase 1
Phase 1
SGR-1505
B-Cell Non-Hodgkin Lymphoma
Phase 1
SGR-3515
Solid Tumor

📅 Upcoming

Nov 4, 2026
earnings
$SDGR18.63-0.11%
in 3mo
Schrodinger, Inc. earnings
Schrodinger, Inc.
→

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Insider activity

source: SEC Form 4

open-market buys + sells

  • Apr 17, 26SELLFarid Ramy· President & CEO43,000 sh @ $12.21−$525K↗
  • Apr 16, 26SELLFarid Ramy· President & CEO43,000 sh @ $12.33−$530K↗
  • Apr 16, 26SELLJain Rachit· EVP & CFO844 sh @ $12.75−$11K↗
  • Mar 6, 26SELLHerman Jenny· CAO608 sh @ $12.84−$8K↗
  • Mar 5, 26SELLFarid Ramy· President & CEO3,661 sh @ $12.91−$47K↗
  • Mar 5, 26SELLJain Rachit· EVP & CFO1,631 sh @ $12.90−$21K↗
  • Mar 5, 26SELLAkinsanya Karen· See Remarks1,366 sh @ $12.90−$18K↗
  • Mar 5, 26SELLLorton Kenneth Patrick· EVP, CTO & COO, Software1,222 sh @ $12.90−$16K↗
  • Mar 5, 26SELLTran Yvonne· EVP, CLO & CPO1,094 sh @ $12.89−$14K↗
  • Mar 5, 26SELLHerman Jenny· CAO775 sh @ $12.85−$10K↗
  • Mar 4, 26SELLAbel Robert Lorne· See Remarks1,300 sh @ $12.81−$17K↗
  • Mar 2, 26SELLFarid Ramy· President & CEO5,560 sh @ $11.90−$66K↗
  • Mar 2, 26SELLAkinsanya Karen· See Remarks2,206 sh @ $11.99−$26K↗
routine RSU / option mechanics (6)
  • Apr 17, 26option exerciseFarid Ramy · President & CEO74,527 sh
  • Apr 17, 26option exerciseFarid Ramy · President & CEO43,000 sh
  • Apr 17, 26option exerciseFarid Ramy · President & CEO43,000 sh
  • Apr 17, 26option exerciseFarid Ramy · President & CEO74,527 sh
  • Apr 16, 26option exerciseFarid Ramy · President & CEO43,000 sh
  • Apr 16, 26option exerciseFarid Ramy · President & CEO43,000 sh
🐶 Hiring Signal
next earnings Nov 4, 2026
No open roles indexed yet — view Schrodinger, Inc. jobs →

News

no news has mentioned this company yet
identifiers
ticker
$SDGR
SEC CIK
0001490978
country
US
source
sec_tickers
top tags
Oncology2DLBCL1
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 11m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?